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Secondary carinal Y-stent implantation for best multimodality 
treatment of advanced lung cancer cases
Karakoca, Yalcin1 Karaagac, Guler1 Aydemir, Cuneyt2 
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gery, Istanbul, Turkey 
We evaluated the effects and results of our endobronchial treatment 
modalities in 13 patients whose oncologic treatments were stopped be-
cause of postobstructive pneumonia and atelectasis due to left second-
ary carinal tumor.
Three of the patients were females and 10 of them were males. The 
mean age was 55 years (49-63). The diagnosis was metastatic lung can-
cer in 2 cases, small cell lung cancer in 1 case and non-small cell lung 
cancer in 10 cases. In all cases chemotherapeutic agents were stopped 
due to postobstructive pneumonia and fever; radiotherapy could not 
be applied because of atelectasis. Endobronchial treatments were per-
formed for tumoral lesion in left secondary carinal region and modiﬁed 
y-stents were implanted. The relief of the postobstructive pneumonia 
and atelectasis were provided in 12 of the cases. In these cases, radio-
therapy and chemotherapy treatments were initiated.
Therapeutic bronchoscopic procedures are used in lung cancer cases 
routinly, but no y-stent implantation for secondary carinal lesions are 
reported. We believe that this procedure will provide a chance to treat 
lung cancer patients.
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Easy endobronchial resection technique with a new device
Karakoca, Yalcin1 Karaagac, Guler1 Aydemir, Cuneyt2 
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Various endobronchial resection methods (Nd-YAG/Nd-YAP laser, 
Argon plasma coagulation, cryotherapy, etc.) could be performed for 
endoluminal tumors and lesions. Balloon dilatation and tamponade are 
widely used with other endobronchial methods for control of bleeding 
or dilatation. We developed a new resection technique and designed a 
special balloon for resecting endoluminal tumoral lesions. This device 
is a balloon catheter covered with a special web-shaped material avail-
able in various sizes. We used resector balloon in 44 interventions for 
resecting endobronchial tumors and also control of bleeding and dilata-
tions were successfully achieved during the procedures. Endobronchial 
tumor resection becomes a simpler and safer method with the use of 
this special balloon.
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The utility of MAGE gene detection in bronchial washing fluid in 
patients with peripheral NSCLC
Kim, Suhyun1 Kim, Hojoong12 Koh, Won-Jung12 Suh, Gee Young12 
Chung, Man Pyo12 Kwon, O Jung12 
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Background: The melanoma antigen (MAGE)-encoding genes are 
known to be expressed in various cancer cells, including non-small cell 
lung cancer (NSCLC), and silent in all normal tissues except testis. In 
patients with peripheral NSCLC, bronchial washing ﬂuid could be used 
to detect MAGE gene, suggesting the diagnosis of lung cancer. In order 
to evaluate the diagnostic utility of MAGE test in patients with periph-
eral NSCLC, bronchial washing ﬂuid was investigated in patients with 
peripheral pulmonary nodule, which was invisible by bronchoscopy.
Methods: Bronchial washing ﬂuid from 52 patients was used for cy-
tologic examination and MAGE gene detection, using RT-nested-PCR 
of A1-A6 mRNA. Results were compared to ﬁnal diagnosis of patients 
conﬁrmed by pathology.
Results: Among the 52 subjects, NSCLC was diagnosed in 35 patients 
and benign pulmonary diseases in 17. The MAGE mRNA was detected 
in 16 of 35 (45.7%) NSCLC patients, while conventional cytology ex-
aminations revealed positive in 4 of 35 (11.4%). None of the expression 
of MAGE was observed in 17 benign pulmonary disease patients.
Conclusion: The MAGE test of bronchial washing ﬂuid could be help-
ful for the diagnosis of peripheral NSCLC with excellent speciﬁcity.
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Background: Mediastinal lymph node metastasis is one of the most 
principal prognostic factors in lung cancer treatment. N2 patients have 
a poor prognosis compared to N1, N0 cases. Histological diagnosis 
of mediastinal lymph node metastasis is necessary for the indication 
of surgery. There are several methods to examine the mediastinal 
lymphadenopathy, such as mediastinoscopy, endobronchial ultrasound- 
guided trans-bronchial needle aspiration (EBUS-TBNA) and etc. but it 
is neither practical nor clinically possible, however, to use mediastinos-
copy or EBUS for all patients with primary lung cancer. 
Methods: A prospective phase II study of indications for surgery, using 
video-assisted mediastinoscopy (VAM) and EBUS-TBNA to detect 
mediastinal lymph node metastasis was conducted in patients with 
resectable primary lung cancer of clinical stages I–IIIA. Indications 
for VAM were based on tumor size, CT ﬁndings and tumor markers, 
and patients were placed in group V ( VAM or EBUS) or group A ( 
thoracotomy without VAM) accordingly. EBUS-TBNA was performed 
if the CT ﬁndings showed mediastinal lymph nodes larger than 15 
mm in the shortest axis. Mediastinal lymph node involvement con-
ﬁrmed by VAM or EBUS was treated with chemotherapy followed by 
thoracotomy (group C) or radiotherapy (group D), and cases without 
detected metastasis underwent thoracotomy and systematic lymph node 
dissection (group B).
Group A patients had primary tumor resection and lymph node sam-
pling and group C patients, tumor resection and extended dissection of 
mediastinal lymph nodes via median sternotomy.
Results: Of the 500 eligible cases who were introduced to our center 
between Oct. 1998 and Des.2006, 249 underwent VAM (group V) 
and 217 had thoracotomy without VAM (group A). EBUS-TBNA was 
indicated for 34 patients. Of the VAM patients, 189 negative patients 
for metastasis received thoracotomy and 60 positive cases received 2 
courses of chemotherapy and 28 responders received thoracotomy and 
32 non-responders received radiation or best supportive care. Twelve 
negative cases by EBUS-TBNA received thoracotomy and 22 positive 
cases received chemotherapy. Six responders received thoracotomy and 
16 non-responders received radiation. The two- and 5- year survival 
rates of groups A, and B were 94.8%, and 90.0% (group A), and 90.8% 
and 59.1% (group B), respectively, while the 2-year rate in Group C 
was 68.0%.
Conclusions: We have demonstrated the usefulness of indication 
criteria for VAM and EBUS for the selection of candidates for primary 
lung cancer surgery. These indication criteria enabled us to avoid doing 
valueless examinations and to avoid unnecessary thoracotomy. The 
more favorable group A outcomes indicated both successful selection 
by these criteria of patients not requiring mediastinal examination, and 
superﬂuity of complete lymph node dissection, proper lymph nodes 
sampling being sufﬁcient for staging. 
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Prognotic value of plasma D-Dimer levels in lung carsinoma
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The plasma concentrations of several proteases of the clothing system 
have been shown to predicy prognosis in malignancy.This study is 
aimed to investigate the prognostic value of plasma levels of D-Dimer 
and other clothing system parameters in lung cancer.
Between 2004-2005 years, 100 new diagnosed lung cancer patients 
and and 25 healty person control groups were evaluated before treat-
ment. These patiens has’t a history of clothing system disorder or 
anticoaqulant therapy. Patients plasma D-Dimer and protrombine time, 
APTT, INR, biochemical parameters and blood count analysis were cal-
culated. Patients lung cancer stages, age, histology, thjerapy modalities 
( chemotherapy cycles, radiotherapy ), therapy results, survival times 
were determined. 
Multivariate statistical analysis was carried out using the Cox’s pro-
portional hazards model. Patients median age was 67; 86 were male. 
Patients stages were; 65 % local advanced, 35% advanced disease, 
(stage 4). Histologic gropus were; 72% nonsmall cell carsinoma, 28% 
small cell carsinoma. Patients median D-Dimer levels is 1250 mgr/dl 
that is signiﬁcantly higher than control groups. Survival times was 
signiﬁcantly higher in low D-Dimer patients( p(<)<0.05). The plasma 
levels of D-dimer predicted survival independently from the clinical 
stage of disease, histological type and performance status (HR=5,1; 
95% conﬁdence interval ). Plasma D-Dimer levels was signiﬁcantly 
higer in metastatic disease ( p<(<)0.01) .
As a result: These results suggest that plasma levels of D-dimer might 
be useful for predicting the clinical outcome in patients with lung can-
cer. However, further prospective studies are needed in a larger popula-
tion to conﬁrm about it and it’s cutt off point in malignansy.
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Artificial intelligence, system analysis and simulation modeling for 
recognition of lung cancer distant metastases
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liai, Lithuania
Purpose: It was well-known, that survival of lung cancer (LC) patients 
(LCP) with distant metastases (M1) takes several months. The search 
of markers for recognition of M1 was realized.
Methods: In trial (1986-2006) consecutive asimptomatic cases after 
surgery, monitored 242 LCP (males=204, females=38; age=57.4±8.9 
years; tumor size=4.6±2.3 cm; pneumonectomies=22, bi/lobec-
tomies=125, segmentectomies=54, exploratory thoracotomies and biop-
sies=41) with pathologic stage T1-4N0-3M0-1 (squamous=115, adeno-
carcinoma=97, large cell=30, T1=93, T2=67, T3=45, T4=37; N0=148, 
N1=5, N2=19; N3=70; G1=56, G2=69, G3=117; M0=147, M1=95) 
were reviewed. Variables selected for study were input levels of im-
munity blood parameters (IgG, IgM, IgA, natural antibodies, circulat-
ing immune complexes, percentage, absolute count and total population 
number of T-lymphocytes, B-cells, CD4, CD8, K-cells, CD1, CDw26, 
monocytes, CD4+2H, CD8+VV, CD4/CD8, leukocytes, lymphocytes, 
polymorphonuclear and sticknuclear leukocytes, NST-tests, indexes of 
stimulation of leukocytes (IS1-2), index of thymus function, phagocytic 
number, phagocyte index, index of complete phagocytosis), sex, age, 
TNMG. Representativeness of samplings was reached by means of 
randomization based on unrepeated random selection. Logistic regres-
sion, multi-factor clustering, discriminant analysis, structural equation 
modeling, Monte Carlo, bootstrap simulation and neural networks 
computing were used to determine any signiﬁcant overall regularity. 
Results: Logistic regression analysis displayed that detection of M1 
signiﬁcantly depended on: B-cells, K-cells, NST-spontaneous, IS2, 
